本页面由Tiger Trade Technology Pte. Ltd.提供服务

Nurix Therapeutics

19.30
+0.44002.33%
盘后19.18-0.1173-0.61%19:29 EDT
成交量:213.48万
成交额:4,157.17万
市值:19.96亿
市盈率:-6.10
高:19.99
开:18.99
低:18.92
收:18.86
52周最高:22.50
52周最低:8.20
股本:1.03亿
流通股本:8,636.18万
量比:0.78
换手率:2.47%
股息:- -
股息率:- -
每股收益(TTM):-3.1650
每股收益(LYR):-3.0514
净资产收益率:-61.40%
总资产收益率:-31.50%
市净率:4.15
市盈率(LYR):-6.32

数据加载中...

2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/24

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/08

重要事件披露

Form 8-K - Current report
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

重要事件披露

Form 8-K - Current report
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/28

重要事件披露

Form 8-K - Current report